128 related articles for article (PubMed ID: 2853876)
21. Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
Barton AC; Moore KE; Demarest KT
J Neural Transm; 1987; 68(1-2):25-39. PubMed ID: 2879883
[TBL] [Abstract][Full Text] [Related]
22. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
[TBL] [Abstract][Full Text] [Related]
23. Striatal synaptosomal dopamine synthesis: evidence against direct regulation by an autoreceptor mechanism.
Compton DR; Johnson KM
Eur J Pharmacol; 1985 Apr; 110(2):157-62. PubMed ID: 2859213
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of tyrosine hydroxylase activity by cyclic AMP in synaptosomes and in soluble striatal enzyme preparations.
Goldstein M; Bronaugh RL; Ebstein B; Roberge C
Brain Res; 1976 Jun; 109(3):563-74. PubMed ID: 6124
[TBL] [Abstract][Full Text] [Related]
25. Dopamine synthesis in rat brain striatal synaptosomes. II. Dibutyryl cyclic adenosine 3':5'-monophosphoric acid and 6-methyltetrahydropterine-induced synthesis increases without an increase in endogenous dopamine release.
Patrick RL; Barchas JD
J Pharmacol Exp Ther; 1976 Apr; 197(1):97-104. PubMed ID: 177758
[TBL] [Abstract][Full Text] [Related]
26. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
Clark D; Hjorth S; Carlsson A
Eur J Pharmacol; 1984 Oct; 106(1):185-9. PubMed ID: 6099268
[TBL] [Abstract][Full Text] [Related]
27. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
Galloway MP; Wolf ME; Roth RH
J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
[TBL] [Abstract][Full Text] [Related]
28. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.
L'hirondel M; Chéramy A; Godeheu G; Artaud F; Saiardi A; Borrelli E; Glowinski J
Brain Res; 1998 May; 792(2):253-62. PubMed ID: 9593923
[TBL] [Abstract][Full Text] [Related]
29. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
30. Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals?
el Mestikawy S; Hamon M
J Neurochem; 1986 Nov; 47(5):1425-33. PubMed ID: 2876053
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine hydroxylase phosphorylation in rat brain striatal synaptosomes.
Colby KA; Thompson TL; Patrick RL
Brain Res; 1989 Jan; 478(1):103-11. PubMed ID: 2564295
[TBL] [Abstract][Full Text] [Related]
32. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.
Yi SJ; Johnson KM
Pharmacol Biochem Behav; 1990 Jul; 36(3):457-61. PubMed ID: 1974064
[TBL] [Abstract][Full Text] [Related]
33. Amphetamine- and phenylethylamine-induced alterations in dopamine synthesis regulation in rat brain striatal synaptosomes.
Roberts MM; Patrick RL
J Pharmacol Exp Ther; 1979 Apr; 209(1):104-10. PubMed ID: 430370
[TBL] [Abstract][Full Text] [Related]
34. Dopamine autoreceptor stimulation increases protein carboxyl methylation in striatal slices.
Wolf ME; Roth RH
J Neurochem; 1985 Jan; 44(1):291-8. PubMed ID: 3964833
[TBL] [Abstract][Full Text] [Related]
35. Catecholamine synthesis regulation in hypothalamic synaptosomes.
Haycock DA; Patrick RL
Brain Res; 1981 Jun; 214(2):371-85. PubMed ID: 6263421
[TBL] [Abstract][Full Text] [Related]
36. Striatal dopamine release in vitro: a beta-adrenoceptor-regulated response not mediated through cyclic AMP.
Reisine T; Chesselet MF; Glowinski J
J Neurochem; 1982 Oct; 39(4):976-81. PubMed ID: 6181195
[TBL] [Abstract][Full Text] [Related]
37. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
Suarez-Roca H; Lovenberg T; Cubeddu LX
J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of synaptosomal dopamine synthesis by corticotropin-releasing factor in rat striatum: role of Ca2+-dependent mechanisms.
Olianas MC; Onali P
Eur J Pharmacol; 1989 Jul; 166(2):165-74. PubMed ID: 2477258
[TBL] [Abstract][Full Text] [Related]
39. Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes.
Bräutigam M; Kittner B; Laschinski G
Mol Pharmacol; 1985 Dec; 28(6):515-20. PubMed ID: 3935908
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment.
White FJ; Wang RY
Brain Res; 1984 Sep; 309(2):283-92. PubMed ID: 6478223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
